What Samantha McLemore bought and sold in Q4 2025
In Q4 2025, Samantha McLemore (Patient Capital Management) opened 2 new positions — including CHYM (2.0%), FISV (0.7%), added to 5, trimmed 8, exited 3 (ANGI, KOS, MSTR). The book stood at $2.59B across 40 positions, filed Feb 13, 2026.
2New5Added8Trimmed3Exited
New positions (2)
Added to (5)
Trimmed (8)
- PGENPrecigen Inc-29% shares · 3.0% · $78M
- UBSUbs Group AG-21% shares · 2.1% · $55M
- EXPEExpedia Group Inc-30% shares · 1.9% · $50M
- DALDelta Air Lines Inc-21% shares · 1.8% · $47M
- SOFISofi Technologies Inc-47% shares · 1.2% · $31M
- PLAYDave & Buster's Entertainmen-22% shares · 1.0% · $27M
- BABAAlibaba Group Holding-sp Adr-80% shares · 0.6% · $15M
- PTONPeloton Interactive Inc-a-26% shares · 0.4% · $12M
Exited (3)
Samantha McLemore's other filings
Changes vs the prior quarter's 13F, long US equity positions only (no shorts, options, or non-US listings). ADD/TRIM are share- count changes of ±20% or more. Sourced from SEC EDGAR. Not investment advice.